Not all people with CLL have to have therapy. Regardless of all recent innovations, the iwCLL even now recommends watchful observation for clients with asymptomatic sickness.86 This advice is based on at least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Anda pasti https://colint123cti4.blogthisbiz.com/profile